1
|
Fields AP, Frederick LA and Regala RP:
Targeting the oncogenic protein kinase Ciota signalling pathway for
the treatment of cancer. Biochem Soc Trans. 35:996–1000. 2007.
|
2
|
Kojima Y, Akimoto K, Nagashima Y, et al:
The overexpression and altered localization of the atypical protein
kinase C lambda/iota in breast cancer correlates with the
pathologic type of these tumors. Hum Pathol. 39:824–831. 2008.
|
3
|
Takagawa R, Akimoto K, Ichikawa Y, et al:
High expression of atypical protein kinase C lambda/iota in gastric
cancer as a prognostic factor for recurrence. Ann Surg Oncol.
17:81–88. 2010.
|
4
|
Wang JM, Li Q, Du GS, Lu JX and Zou SQ:
Significance and expression of atypical protein kinase C-iota in
human hepatocellular carcinoma. J Surg Res. 154:143–149. 2009.
|
5
|
Regala RP, Weems C, Jamieson L, et al:
Atypical protein kinase C iota is an oncogene in human non-small
cell lung cancer. Cancer Res. 65:8905–8911. 2005.
|
6
|
Kudo S: Endoscopic mucosal resection of
flat and depressed types of early colorectal cancer. Endoscopy.
25:455–461. 1993.
|
7
|
Kudo S, Kashida H, Tamura T, et al:
Colonoscopic diagnosis and management of nonpolypoid early
colorectal cancer. World J Surg. 24:1081–1090. 2000.
|
8
|
Ohno Y, Terai T, Ogihara T, Hirai S and
Miwa H: Laterally spreading tumor: clinicopathological study in
comparison with the depressed type of colorectal tumor. J
Gastroenterol Hepatol. 16:770–776. 2001.
|
9
|
Hiraoka S, Kato J, Tatsukawa M, et al:
Laterally spreading type of colorectal adenoma exhibits a unique
methylation phenotype and K-ras mutations. Gastroenterology.
131:379–389. 2006.
|
10
|
Hassan A, Yerian LM, Kuan SF, Xiao SY,
Hart J and Wang HL: Immunohistochemical evaluation of adenomatous
polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and
retinoblastoma protein expression in syndromic and sporadic fundic
gland polyps. Hum Pathol. 35:328–334. 2004.
|
11
|
Oka H, Shiozaki H, Kobayashi K, et al:
Expression of E-cadherin cell adhesion molecules in human breast
cancer tissues and its relationship to metastasis. Cancer Res.
53:1696–1701. 1993.
|
12
|
Oka Y, Naito I, Manabe K, et al:
Distribution of collagen type IV alpha1–6 chains in human normal
colorectum and colorectal cancer demonstrated by immunofluorescence
staining using chain-specific epitope-defined monoclonal
antibodies. J Gastroenterol Hepatol. 17:980–986. 2002.
|
13
|
Oka S, Tanaka S, Kanao H, Oba S and
Chayama K: Therapeutic strategy for colorectal laterally spreading
tumor. Dig Endosc. 21(Suppl 1): S43–S46. 2009.
|
14
|
Kaku E, Oda Y, Murakami Y, et al:
Proportion of flat- and depressed-type and laterally spreading
tumor among advanced colorectal neoplasia. Clin Gastroenterol
Hepatol. 9:503–508. 2011.
|
15
|
Takahashi T, Nosho K, Yamamoto H, et al:
Flat-type colorectal advanced adenomas (laterally spreading tumors)
have different genetic and epigenetic alterations from
protruded-type advanced adenomas. Mod Pathol. 20:139–147. 2007.
|
16
|
Tanos B and Rodriguez-Boulan E: The
epithelial polarity program: machineries involved and their
hijacking by cancer. Oncogene. 27:6939–6957. 2008.
|
17
|
Lelievre SA: Tissue polarity-dependent
control of mammary epithelial homeostasis and cancer development:
an epigenetic perspective. J Mammary Gland Biol Neoplasia.
15:49–63. 2010.
|
18
|
Bosman FT, de Bruine A, Flohil C, et al:
Epithelial-stromal interactions in colon cancer. Int J Dev Biol.
37:203–211. 1993.
|
19
|
Debruyne D, Oliveira MJ, Bracke M, Mareel
M and Leroy A: Colon cancer cells: pro-invasive signalling. Int J
Biochem Cell Biol. 38:1231–1236. 2006.
|
20
|
Van Aken J, Cuvelier CA, De Wever N, et
al: Immunohistochemical analysis of E-cadherin expression in human
colorectal tumours. Pathol Res Pract. 189:975–978. 1993.
|
21
|
Wong NA and Pignatelli M: Beta-catenin - a
linchpin in colorectal carcinogenesis? Am J Pathol. 160:389–401.
2002.
|
22
|
Horst D, Reu S, Kriegl L, Engel J,
Kirchner T and Jung A: The intratumoral distribution of nuclear
beta-catenin is a prognostic marker in colon cancer. Cancer.
115:2063–2070. 2009.
|
23
|
Hashimoto S, Higaki S, Amano A, et al:
Relationship between molecular markers and endoscopic findings in
laterally spreading tumors. J Gastroenterol Hepatol. 22:30–36.
2007.
|
24
|
Wang J, Wang X, Gong W, Mi B, Liu S and
Jiang B: Increased expression of beta-catenin, phosphorylated
glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally
spreading colorectal tumors. J Histochem Cytochem. 57:363–371.
2009.
|
25
|
Wodarz A and Nathke I: Cell polarity in
development and cancer. Nat Cell Biol. 9:1016–1024. 2007.
|
26
|
Gonzalez-Mariscal L, Tapia R and Chamorro
D: Crosstalk of tight junction components with signaling pathways.
Biochim Biophys Acta. 1778:729–756. 2008.
|
27
|
Murray NR, Weems J, Braun U, Leitges M and
Fields AP: Protein kinase C betaII and PKCiota/lambda:
collaborating partners in colon cancer promotion and progression.
Cancer Res. 69:656–662. 2009.
|
28
|
Perander M, Bjorkoy G and Johansen T:
Nuclear import and export signals enable rapid nucleocytoplasmic
shuttling of the atypical protein kinase C lambda. J Biol Chem.
276:13015–13024. 2001.
|